Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Advances in clinical applications of cardiovascular magnetic resonance imaging.

Bandettini WP, Arai AE.

Heart. 2008 Nov;94(11):1485-95. doi: 10.1136/hrt.2007.119016. Epub 2008 Jan 20. Review.

2.

Clinical applications of cardiac magnetic resonance imaging.

Pilz G, Heer T, Harrer E, Ali E, Hoefling B.

Minerva Cardioangiol. 2009 Jun;57(3):299-313. Review.

PMID:
19513011
3.

Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial).

Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schönberg SO, Debl K, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T; MR-IMPACT investigators.

J Cardiovasc Magn Reson. 2012 Sep 2;14:61.

4.

Myocardial ischemia and viability by cardiac magnetic resonance: the international experience and the Greek reality.

Mavrogeni S, Bratis K, Kolovou G.

Hellenic J Cardiol. 2012 Jan-Feb;53(1):55-62. Review. No abstract available.

5.

[Indications for cardiovascular magnetic resonance imaging].

Nagel E, Kelle S, Fleck E.

Med Klin (Munich). 2005 Apr 15;100(4):219-25. Review. German.

PMID:
15834533
6.

Cardiac magnetic resonance imaging and ischaemic cardiomyopathies: what are the indications?

Wright J, Bogaert J.

Presse Med. 2011 Sep;40(9 Pt 2):e379-89. doi: 10.1016/j.lpm.2010.09.031. Epub 2011 Jun 28. Review.

PMID:
21715131
7.

Cardiac MRI: A General Overview with Emphasis on Current Use and Indications.

Pfeiffer MP, Biederman RW.

Med Clin North Am. 2015 Jul;99(4):849-61. doi: 10.1016/j.mcna.2015.02.011. Review.

PMID:
26042886
8.

[Cardiovascular magnetic resonance imaging in childhood - clinical indications and case studies].

Voges I, Jerosch-Herold M, Plagemann T, Hart C, Hansen T, Helle M, Kramer HH, Rickers C.

Klin Padiatr. 2010 Jan-Feb;222(1):3-12. doi: 10.1055/s-0029-1239526. Epub 2010 Jan 18. Review. German.

PMID:
20084585
9.

Myocardial perfusion imaging by cardiac magnetic resonance.

Schwitter J.

J Nucl Cardiol. 2006 Nov;13(6):841-54. Review.

PMID:
17174815
10.

Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial.

Greenwood JP, Motwani M, Maredia N, Brown JM, Everett CC, Nixon J, Bijsterveld P, Dickinson CJ, Ball SG, Plein S.

Circulation. 2014 Mar 11;129(10):1129-38. doi: 10.1161/CIRCULATIONAHA.112.000071. Epub 2013 Dec 19.

11.

2014 Korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology.

Yoon YE, Hong YJ, Kim HK, Kim JA, Na JO, Yang DH, Kim YJ, Choi EY, The Korean Society of Cardiology and the Korean Society of Radiology.

Korean J Radiol. 2014 Nov-Dec;15(6):659-88. doi: 10.3348/kjr.2014.15.6.659. Epub 2014 Nov 7. Review.

12.

Risk stratification for therapeutic management and prognosis.

Coelho-Filho OR, Nallamshetty L, Kwong RY.

Heart Fail Clin. 2009 Jul;5(3):437-55, vii. doi: 10.1016/j.hfc.2009.02.010. Review.

PMID:
19564018
13.

Coronary artery disease: comprehensive evaluation by cardiovascular magnetic resonance imaging.

Tan RS, Chen KK.

Ann Acad Med Singapore. 2004 Jul;33(4):437-43. Review.

14.

Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance.

Schwitter J, Arai AE.

Eur Heart J. 2011 Apr;32(7):799-809. doi: 10.1093/eurheartj/ehq481. Epub 2011 Mar 11. Review.

15.

Combined non-invasive functional and anatomical diagnostic work-up in clinical practice: the magnetic resonance and computed tomography in suspected coronary artery disease (MARCC) study.

Groothuis JG, Beek AM, Brinckman SL, Meijerink MR, van den Oever ML, Hofman MB, van Kuijk C, van Rossum AC.

Eur Heart J. 2013 Jul;34(26):1990-8. doi: 10.1093/eurheartj/eht077. Epub 2013 Mar 7.

16.

Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Senthilkumar A, Majmudar MD, Shenoy C, Kim HW, Kim RJ.

Heart Fail Clin. 2009 Jul;5(3):349-67, vi. doi: 10.1016/j.hfc.2009.02.009. Review.

17.

Pharmacological stress cardiovascular magnetic resonance.

Chotenimitkhun R, Hundley WG.

Postgrad Med. 2011 May;123(3):162-70. doi: 10.3810/pgm.2011.05.2295. Review.

18.

Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease.

Jogiya R, Kozerke S, Morton G, De Silva K, Redwood S, Perera D, Nagel E, Plein S.

J Am Coll Cardiol. 2012 Aug 21;60(8):756-65. doi: 10.1016/j.jacc.2012.02.075. Epub 2012 Jul 18.

19.

Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease.

Jerosch-Herold M, Kwong RY.

Curr Opin Cardiol. 2008 Nov;23(6):599-606. doi: 10.1097/HCO.0b013e328312c2f5. Review.

20.

Value of vasodilator stress myocardial contrast echocardiography and magnetic resonance imaging for the differential diagnosis of ischemic versus nonischemic cardiomyopathy.

Mor-Avi V, Koch R, Holper EM, Goonewardena S, Coon PD, Min JK, Fedson S, Ward RP, Lang RM.

J Am Soc Echocardiogr. 2008 May;21(5):425-32. doi: 10.1016/j.echo.2007.10.034. Epub 2008 Jan 9.

PMID:
18187290
Items per page

Supplemental Content

Write to the Help Desk